Investing

Wells Fargo sees this biotech stock rallying 75% in its bull case

The success of one of Kymera Therapeutics' experimental treatments could mean more upside ahead for the stock, according to Wells Fargo.

adminadmin
Dec 3, 2024 - 12:00
 0  2
Wells Fargo sees this biotech stock rallying 75% in its bull case
The success of one of Kymera Therapeutics' experimental treatments could mean more upside ahead for the stock, according to Wells Fargo.
Read More

Tags:

Previous Article

What the biggest investors are buying entering 2025 — with Trump and Fed in mind

Next Article

December is typically a good month for stocks, and technicians expect another go...

admin
admin

Related Posts

Inflation isn’t stopping people from dining out, but consumers are getting savvy with spending

Inflation isn’t stopping people from dining out, but co...

admin Jun 29, 2024  0  12

The key levels to watch on Nvidia's stock chart with its big earnings report almost here

The key levels to watch on Nvidia's stock chart with it...

admin May 23, 2024  0  5

Alphabet could be in for a tough period ahead, analysts warn

Alphabet could be in for a tough period ahead, analysts...

admin Jul 25, 2024  0  6